Cell Death and Disease (Oct 2020)
Correction: ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
